rewirebio.iobenchmarks
Dataset

PerturbPFN synthetic prior, 1,024 held-out episodes

Fresh episodes sampled from PerturbPFN's hierarchical synthetic prior, each a 40 to 60 gene modular graph with synthetic drugs, dose-dependent sparse targets and simulated zero-inflated log-normal responses, with the true graph, targets and strengths known.

Evaluation results

1 evaluation · 10 results. Different protocols are not a single leaderboard.

Filter evaluations

Applied filters: All linked evaluations

Exact evaluated configurations and original reported results
Tested configurationProtocol and datasetFindingEvidence and details
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.298 AUPRC (Latent graph: all directed non-self edges ranked by predicted edge probability, edge prevalence 0.0363; PerturbPFN in-prior synthetic episodes)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Graph', row "AUPRC ↑"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.813 AUROC (Latent graph: all directed non-self edges ranked by predicted edge probability; PerturbPFN in-prior synthetic episodes)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Graph', row "AUROC ↑"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.326 F1 (Latent graph edges after keeping the top-scoring acyclic edges up to the true edge count (density-matched DAG projection); PerturbPFN in-prior synthetic episodes)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Graph', row "Proj. F1 ↑"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
-0.138 Negative log likelihood (Mean negative log-likelihood of query responses under the predicted zero-inflated log-normal distribution; PerturbPFN in-prior synthetic episodes)
unit-unreported · lower

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Strength / Response', row "Obs. NLL ↓"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.744 Cosine similarity (Predicted against true mean response shift relative to control, both centred across genes; PerturbPFN in-prior synthetic episodes)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Strength / Response', row "∆ cosine ↑"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.939 Magnitude ratio (Mean absolute predicted intervention strength over mean absolute true strength on true target nodes; 1 is the correct scale; PerturbPFN in-prior synthetic episodes)
unitless · unknown

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Strength / Response', row "|ψ| ratio →1"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.786 AUPRC (Intervention targets: node-wise target probabilities; PerturbPFN in-prior synthetic episodes)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Target', row "AUPRC ↑"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.933 AUROC (Intervention targets: node-wise target probabilities; PerturbPFN in-prior synthetic episodes)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Target', row "AUROC ↑"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.765 F1 (Intervention targets: node-wise probabilities thresholded at 0.5; PerturbPFN in-prior synthetic episodes)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Table 1, block 'Target', row "F1 ↑"
Configuration: PerturbPFN step-3100 checkpoint, in-context forward passProtocol: PerturbPFN in-prior latent recovery on held-out synthetic episodes (Table 1)
Dataset: PerturbPFN synthetic prior, 1,024 held-out episodes
0.629 F1 (Intervention targets: straight-through top-k gate used in the decoder rollout (k = 3, Table 6); PerturbPFN in-prior synthetic episodes)
unitless · higher

Uncertainty: Not reported by the source: No spread is printed for this value.

Coverage: Not reported scored / Not reported eligible

Author-reported evaluation · Source checked
Methods, coverage and source

PerturbPFN on in-prior latent recovery (PerturbPFN Table 1)

perturbpfn-20261115-protocol-in-prior-latent-recovery

Aggregation: Not reported

PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1) · Section 4.1 'Results', sentence 'The straight-through top-k gate used by the decoder obtains a lower F1 of 0.6287'

Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.

Research readiness

0 of 4 readiness checks met. These checks assess whether the evidence supports a reproducible investigation; a source-checked score alone does not meet them.

Readiness checks, gaps and artifacts

Release 2026-11-21-c8bea25e5abb · Evidence verified: Not verified

Evidence incomplete

Replay metrics

Exact outcomes, predictions, identifiers and evaluator are connected.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified

Verified: Not verified

Evidence incomplete

Investigate discrepancies

Replay evidence includes annotations and an assessment of dependence. Unknown independence permits descriptive analysis only.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Metrics are recomputed from the saved predictions: not yet verified
  • Sample annotations are recorded: not yet verified
  • Dependence between samples is assessed: not yet verified

Verified: Not verified

Evidence incomplete

Run locally

A pinned recipe describes the inputs, environment and resource requirements.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • A pinned run recipe exists: not yet verified
  • Compute requirements are estimated: not yet verified

Verified: Not verified

Evidence incomplete

Validate independently

Separate data and exposure records support an independent test.

Missing or unresolved evidence

  • No verified artifact manifest is linked to this exact record.
  • File checksums match the recorded files: not yet verified
  • Predictions are matched to the right samples: not yet verified
  • Score meaning and direction are confirmed: not yet verified
  • Independent validation data exist: not yet verified
  • Overlap with training data is checked: not yet verified

Verified: Not verified

Readiness describes the evidence in this release. Availability on your computer is checked separately when an investigation runs. Existing data exposure can prevent independent validation even when files are available.

Artifacts and reproduction

No verified artifact manifest is connected to this record yet. The gaps above identify what is needed before analysis can begin.

Dataset and evaluation context

A dataset supplies biological observations. The evaluation protocol defines how those observations are split, used and scored.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

7 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Scope note
1,024 fresh episodes (Section 4.1), scored as 128 held-out synthetic batches (Table 1 caption) of batch size 8 (Table 7). Edge prevalence 0.0363 (Section 4.1 Results). Prior settings in Tables 4 and 5.
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.scope_note

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Source location
Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.source_locator

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Split
Held-out episodes drawn fresh from the prior; not used in training
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.split

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Total
1024
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.total

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Version
Synthetic prior of the final checkpoint, arXiv:2607.23447v1 Appendix A
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.version

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Description
Fresh episodes sampled from PerturbPFN's hierarchical synthetic prior, each a 40 to 60 gene modular graph with synthetic drugs, dose-dependent sparse targets and simulated zero-inflated log-normal responses, with the true graph, targets and strengths known.
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: description

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Name
PerturbPFN synthetic prior, 1,024 held-out episodes
Context-only references
PerturbPFN: Probing the Limits of Synthetic Priors in Drug Perturbation Modelling (arXiv:2607.23447v1)

Original source ↗

Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7

Version: arXiv v1, submitted 2026-07-26
Retrieved: 2026-11-15T20:27:40Z

not individually reviewed

No individual claim review recorded

Audit details

Field: name

Source artifact SHA-256: 42191efa04b45ca04b2be38b51ea374cd9bf891efe2399d331fec9eaeab200b1

Hash scope: Exact bytes of the PDF. Three downloads on 2026-11-15 (20:22Z to 20:27Z) gave identical bytes.

Inspected artifact

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

1 source record and release historyDownload this release (gzip)
Technical metadata and record identifiers

Technical metadata for this record is tracked under stable ID perturbpfn-20261115-data-in-prior-synthetic-episodes.

Source locator: Section 4.1; Table 1 caption; Appendix A; Tables 4, 5 and 7

Related records

Suggest a correction